Statin use vs. average non-HDL cholesterol levels in Luxembourg

Luxembourg: Statin use vs. average non-HDL cholesterol levels was 3.3 in 2018. ▼ Falling

Latest (2018)
3.3
Change on year
unchanged
Rank
95th
of 191 regions
All-time high
4.6
in 1980
All-time low
3.3
in 2016
Years of data
39
1980–2018

Statin use vs. average non-HDL cholesterol levels in Luxembourg, 1980–2018

0123451980199920181980: 4.61981: 4.61982: 4.51983: 4.51984: 4.51985: 4.51986: 4.51987: 4.41988: 4.41989: 4.41990: 4.41991: 4.31992: 4.31993: 4.31994: 4.21995: 4.21996: 4.11997: 4.11998: 41999: 42000: 3.92001: 3.92002: 3.92003: 3.82004: 3.82005: 3.72006: 3.72007: 3.62008: 3.62009: 3.62010: 3.52011: 3.52012: 3.52013: 3.42014: 3.42015: 3.42016: 3.32017: 3.32018: 3.3

Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.

Analysis

Luxembourg recorded 3.3 for statin use vs. average non-hdl cholesterol levels in 2018. That is the lowest value across all 39 years on record.

Compared with earlier readings it is down 8.3% over ten years.

Over the whole period, statin use vs. average non-hdl cholesterol levels in Luxembourg peaked at 4.6 in 1980 and was at its lowest, 3.3, in 2016.

Luxembourg ranks 95th of 191 regions on this measure, in the middle of the range.

The long-run direction has been consistently falling across the 39 years of available data.

Averages by decade

DecadeAverage LowestHighest Years
1980s 4.49 4.4 4.6 10
1990s 4.19 4 4.4 10
2000s 3.75 3.6 3.9 10
2010s 3.4 3.3 3.5 9

Countries ranked near Luxembourg

  1. 95 Algeria 3.3 compare
  2. 95 Azerbaijan 3.3 compare
  3. 95 Bahrain 3.3 compare
  4. 95 Barbados 3.3 compare
  5. 95 Bolivia 3.3 compare
  6. 95 Bosnia and Herzegovina 3.3 compare
  7. 95 Cambodia 3.3 compare
  8. 95 China 3.3 compare
  9. 95 Cuba 3.3 compare
  10. 95 Egypt 3.3 compare
  11. 95 Ghana 3.3 compare
  12. 95 Kiribati 3.3 compare
  13. 95 Laos 3.3 compare
  14. 95 Marshall Islands 3.3 compare
  15. 95 Netherlands 3.3 compare
  16. 95 Spain 3.3 compare
  17. 95 Sri Lanka 3.3 compare
  18. 95 Suriname 3.3 compare
  19. 95 Turkey 3.3 compare
  20. 95 Turkmenistan 3.3 compare
  21. 95 United Kingdom 3.3 compare
  22. 95 United States 3.3 compare

See the full ranking of 191 places →

More reference data data for Luxembourg

All data for Luxembourg →

Frequently asked questions

What is statin use vs. average non-hdl cholesterol levels in Luxembourg?
Statin use vs. average non-hdl cholesterol levels in Luxembourg was 3.3 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
What is the highest statin use vs. average non-hdl cholesterol levels recorded in Luxembourg?
The highest recorded value was 4.6 in 1980.
What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Luxembourg?
The lowest recorded value was 3.3 in 2016.
How does Luxembourg rank for statin use vs. average non-hdl cholesterol levels?
Luxembourg ranks 95th out of 191 regions with data for 2018.
Is statin use vs. average non-hdl cholesterol levels rising or falling in Luxembourg?
Over the last ten years it is down 8.3%. The long-run trend across the full record is falling.
Where does this Luxembourg data come from?
The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.